Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Letter Commentary & Co-Mentions | Period / Date | Action |
|---|---|---|---|
“The manager reduced exposure to the Korean medical aesthetics company after realizing significant profits over the course of the holding period.” | Q2 2025 Jul 21, 2025 | Preview | |
“Faced short-term headwinds in Brazil due to its local distribution partner selling down built-up inventory, but solid growth elsewhere and the seamless integration of recently acquired Ilooda support a constructive outlook.” | Q3 2025 Oct 22, 2025 | Preview |
Read unredacted commentary excerpts, portfolio weight disclosures, and high-conviction theses from hedge fund managers discussing $214150.KQ.
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
